Evaluation and Management of IBS Without Alarm Features
Make a confident, positive diagnosis of IBS based on symptoms alone when alarm features are absent, perform only limited baseline investigations, and avoid unnecessary colonoscopy or extensive testing. 1
Diagnostic Approach
Initial Clinical Assessment
Confirm the cardinal symptoms that define IBS 1:
- Abdominal pain (upper or lower abdomen) that has a clear temporal relationship with altered bowel habit
- Pain relieved or exacerbated by defecation, OR pain present when constipation worsens or diarrhea increases
- Altered bowel habit with abnormal stool frequency and/or consistency for at least 6 months 1
- Assess predominant stool pattern using the Bristol Stool Chart on days when stools are abnormal 1
Document additional supportive features 1:
- Bloating and visible abdominal distension (highly suggestive when present)
- Extraintestinal symptoms: back pain, urological symptoms, gynecological symptoms, insomnia
- Coexisting functional disorders: fibromyalgia, tension headache, chronic fatigue
- History of postinfectious onset, recurrent antibiotics, or psychological trauma
- Medications affecting gut motility (psychotropics, opioids)
Required Baseline Investigations
Perform only these limited tests in primary care or at first secondary care visit 1:
- Full blood count
- C-reactive protein OR erythrocyte sedimentation rate
- Coeliac serology
- Faecal calprotectin (only if diarrhea present AND age <45 years) 1
What NOT to Test
Avoid these investigations in typical IBS 1:
- Hydrogen breath testing for small intestinal bacterial overgrowth
- Hydrogen breath testing for carbohydrate intolerance
- Testing for exocrine pancreatic insufficiency
- Routine colonoscopy (see exceptions below)
When Colonoscopy IS Indicated
Reserve colonoscopy only for these specific situations 1:
Alarm Features Present
- Urgent referral required for alarm symptoms/signs 1
IBS-D with Atypical Features Suggesting Microscopic Colitis
Consider colonoscopy when ≥2 of these risk factors present 1:
- Female sex
- Age ≥50 years
- Coexistent autoimmune disease
- Nocturnal or severe watery diarrhea
- Duration of diarrhea <12 months
- Weight loss
- Use of NSAIDs, PPIs, SSRIs, or statins
Additional Testing for Specific Atypical Presentations
IBS-D with Nocturnal Diarrhea or Prior Cholecystectomy
Consider bile acid diarrhea testing 1:
- 23-seleno-25-homotaurocholic acid (SeHCAT) scanning (preferred)
- Serum 7α-hydroxy-4-cholesten-3-one (reasonable alternative)
- Note: 25-33% of suspected IBS-D patients have abnormal SeHCAT retention 1
IBS-C with Features of Defecatory Disorder
Consider anorectal physiology testing where available to select candidates for biofeedback 1
Patient Education and Communication
Deliver a confident positive diagnosis using clear explanations 1:
Explain IBS as a disorder of gut-brain interaction 1:
- Visceral hypersensitivity is the main pathophysiological mechanism
- Symptoms triggered by diet, stress, intercurrent illness, and eating
- NOT associated with increased cancer risk or mortality 1
- Affects quality of life similarly to inflammatory bowel disease 1
- Chronic condition with fluctuating, recurrent symptoms 1
Set realistic expectations 1:
- Cure is unlikely
- Substantial improvement in symptoms, social functioning, and quality of life IS achievable
- Treatment decisions should be made by the patient with clinician support
Management Framework
General Measures
Recommend regular exercise for all patients, particularly beneficial for constipation with effects lasting up to 5 years 1
Treatment Selection
Direct treatment toward the predominant symptom(s) 1:
- Commence with dietary therapies OR first-line drugs
- Consider patient's previous treatments and preferences 1
- Explain mechanisms of action and rationale within the gut-brain axis framework 1
Referral to Gastroenterology
Refer to secondary care when 1:
- Diagnostic doubt exists
- Symptoms are severe or refractory to first-line treatments
- Patient specifically requests specialist opinion
Common Pitfalls to Avoid
Do not perform colonoscopy for reassurance - there is no evidence patients derive reassurance from normal examination, and yield is extremely low in typical IBS 1
Do not delay diagnosis - up to 80% of IBS patients report at least one alarm symptom, but diagnostic performance of alarm features is modest 1
Do not dismiss the diagnosis as "functional" - validation studies show Rome IV criteria identify IBS-C patients 21 times more likely to have IBS-C than not, and IBS-M patients 11 times more likely after limited workup 1
Establish empathy and active listening - effective doctor-patient relationship improves quality of life, reduces healthcare visits, and enhances treatment adherence 1